Monday, August 01, 2022 10:06:06 AM
Not meant as a Gotcha, just looked like you were using some odd information. I misread your 1.5 billion as the total number of authorized shares you expected post ASM (when they need to request an increase to the share count). Sorry about that.
The thing is, the company can't have 1.5 billion shares now, much less 1.75 billion, because it is more than are authorized. That is why they need to authorize more at the ASM. So the 14.3% figure doesn't really make sense because it is based on a number of authorized/issued shares that will probably never exist (the point of my 1st paragraph response). If they request an increase in authorized shares, as they did in 2019, it is almost certainly going to include more than they need to cover existing shares. So probably at least 2 billion. In addition, as indicated by their late-2021 loan terms, they are likely to issue stock soon after 'official' TLD because they need lots of cash for a large number of upcoming expenses.
This has nothing to do with math, and I don't have any agenda here more than questioning numbers that do not seem to make sense. If you want to feel differently, that is really your problem.
The 10-60 days in specific to ASMs. It is spelled out in the NWBO bylaws that I linked. It is the same (as you note) as in Title 8, Del. Gen. Corp. Code § 222(b):
Sorry, 'Dr. Z' meant nothing to me, as I have never heard of Dr. Z. If you had mentioned iwasadiver, that would have been helpful. As a lawyer, I am loathe to trust double hearsay from people I don't personally know. Especially when the person at the company is not identified.
I appreciate that you and many others seem to think that I am a short out to kill the company because I don't spew enough rainbows and gumdrops. Fortunately, most people's opinions don't mean much to me. What matters to me is NWBO curing cancer patients and me making a $#!&-ton of money on their stock. So, mostly I post responses to what I see as misinformation. Sometimes pro-company, sometimes anti-company. The dangers of over-optimism are almost as significant as the over-pessimism we see here all the time and making overly optimistic statements without anything but faith and speculation to back them makes the work of shorts easier. I am especially sensitive to setting dates the company has not committed to.
Recent NWBO News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM